The results showed that SLC7A11 was higher in CRC, esophageal cancer, head and neck cancer, kidney cancer, liver cancer, lung cancer, pancreatic cancer, and uterus cancer, and lower in lymphoma and ovarian cancer (Figure 2 and Supplementary Table 1). Here, SLC7A11 is linked to lung cancer.